162 related articles for article (PubMed ID: 37174239)
1. Associations of Content and Context of Communication with Prostate-Specific Antigen Testing.
Alford NA; Wongpaiboon M; Luque JS; Harris CM; Tawk RH
Int J Environ Res Public Health; 2023 May; 20(9):. PubMed ID: 37174239
[TBL] [Abstract][Full Text] [Related]
2. Disparities Associated with Shared Decision-making in Prostate Cancer Screening.
Basin MF; Crane K; Basnet A; Chandrasekar T; Shapiro O; Jacob JM; Bratslavsky G; Goldberg H
Eur Urol Focus; 2023 Nov; 9(6):1008-1015. PubMed ID: 37198068
[TBL] [Abstract][Full Text] [Related]
3. Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.
Li J; Zhao G; Hall IJ
Am J Prev Med; 2015 Aug; 49(2):259-63. PubMed ID: 25997905
[TBL] [Abstract][Full Text] [Related]
4. Association between features of patient-provider discussions and routine prostate-specific antigen testing.
Liao JM; Ommerborn MJ; Clark CR
PLoS One; 2017; 12(5):e0177687. PubMed ID: 28520820
[TBL] [Abstract][Full Text] [Related]
5. The Impact of Receipt of Information on Prostate-Specific Antigen Testing on Screening with the Prostate-Specific Antigen Test.
McCormick ME; Haile ZT
J Cancer Educ; 2023 Aug; 38(4):1313-1321. PubMed ID: 36652189
[TBL] [Abstract][Full Text] [Related]
6. Prostate-Specific Antigen Testing Initiation and Shared Decision-Making: Findings from the 2000 and 2015 National Health Interview Surveys.
Li J; Ding H; Richards TB; Martin I; Kobrin S; Marcus PM
J Am Board Fam Med; 2018; 31(4):658-662. PubMed ID: 29986994
[TBL] [Abstract][Full Text] [Related]
7. Physician Consultations, Prostate Cancer Knowledge, and PSA Screening of African American Men in the Era of Shared Decision-Making.
Woods-Burnham L; Stiel L; Wilson C; Montgomery S; Durán AM; Ruckle HR; Thompson RA; De León M; Casiano CA
Am J Mens Health; 2018 Jul; 12(4):751-759. PubMed ID: 29658371
[TBL] [Abstract][Full Text] [Related]
8. National evidence on the use of shared decision making in prostate-specific antigen screening.
Han PK; Kobrin S; Breen N; Joseph DA; Li J; Frosch DL; Klabunde CN
Ann Fam Med; 2013; 11(4):306-14. PubMed ID: 23835816
[TBL] [Abstract][Full Text] [Related]
9. The State of Prescreening Discussions About Prostate-specific Antigen Testing Following Implementation of the 2012 United States Preventive Services Task Force Statement.
Turini GA; Gjelsvik A; Renzulli JF
Urology; 2017 Jun; 104():122-130. PubMed ID: 28322897
[TBL] [Abstract][Full Text] [Related]
10. Prostate cancer screening decision-making in three states: 2013 behavioral risk factor surveillance system analysis.
Li J; Hall IJ; Zhao G
Cancer Causes Control; 2017 Mar; 28(3):235-240. PubMed ID: 28210882
[TBL] [Abstract][Full Text] [Related]
11. Shared decision making in prostate-specific antigen testing with men older than 70 years.
Li J; Berkowitz Z; Richards TB; Richardson LC
J Am Board Fam Med; 2013; 26(4):401-8. PubMed ID: 23833155
[TBL] [Abstract][Full Text] [Related]
12. Recent Patterns in Shared Decision Making for Prostate-Specific Antigen Testing in the United States.
Fedewa SA; Gansler T; Smith R; Sauer AG; Wender R; Brawley OW; Jemal A
Ann Fam Med; 2018 Mar; 16(2):139-144. PubMed ID: 29531105
[TBL] [Abstract][Full Text] [Related]
13. Shared decision making in prostate-specific antigen testing: the effect of a mailed patient flyer prior to an annual exam.
Landrey AR; Matlock DD; Andrews L; Bronsert M; Denberg T
J Prim Care Community Health; 2013 Jan; 4(1):67-74. PubMed ID: 23799692
[TBL] [Abstract][Full Text] [Related]
14. Randomized trial of community health worker-led decision coaching to promote shared decision-making for prostate cancer screening among Black male patients and their providers.
Makarov DV; Feuer Z; Ciprut S; Lopez NM; Fagerlin A; Shedlin M; Gold HT; Li H; Lynch G; Warren R; Ubel P; Ravenell JE
Trials; 2021 Feb; 22(1):128. PubMed ID: 33568208
[TBL] [Abstract][Full Text] [Related]
15. "Shared decision-making" for prostate cancer screening: Is it a marker of quality preventative healthcare?
Golijanin B; Bhatt V; Homer A; Malshy K; Ochsner A; Wales R; Khaleel S; Mega A; Pareek G; Hyams E
Cancer Epidemiol; 2024 Feb; 88():102492. PubMed ID: 38056246
[TBL] [Abstract][Full Text] [Related]
16. Patient Provider Continuity and Prostate Specific Antigen Testing: Impact of Continuity on Receipt of a Non-recommended Test.
Mainous AG; Rooks BJ; Mercado ES; Carek PJ
Front Med (Lausanne); 2021; 8():622541. PubMed ID: 33816522
[No Abstract] [Full Text] [Related]
17. Predictors of attendance for prostate-specific antigen screening tests and prostate biopsy.
Avery KN; Metcalfe C; Vedhara K; Lane JA; Davis M; Neal DE; Hamdy FC; Donovan JL; Blazeby JM
Eur Urol; 2012 Oct; 62(4):649-55. PubMed ID: 22244151
[TBL] [Abstract][Full Text] [Related]
18. Are Men Making Informed Decisions According to the Prostate-Specific Antigen Test Guidelines? Analysis of the 2015 Behavioral Risk Factor Surveillance System.
Cooper DL; Rollins L; Slocumb T; Rivers BM
Am J Mens Health; 2019; 13(2):1557988319834843. PubMed ID: 30836815
[TBL] [Abstract][Full Text] [Related]
19. Shared decision making and prostate-specific antigen based prostate cancer screening following the 2018 update of USPSTF screening guideline.
Jiang C; Fedewa SA; Wen Y; Jemal A; Han X
Prostate Cancer Prostatic Dis; 2021 Mar; 24(1):77-80. PubMed ID: 32296126
[TBL] [Abstract][Full Text] [Related]
20. Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States.
Nguyen DD; Trinh QD; Cole AP; Kilbridge KL; Mahal BA; Hayn M; Hansen M; Han PKJ; Sammon JD
Cancer; 2021 Jan; 127(2):249-256. PubMed ID: 33165954
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
